Join
Live feed
·
PRReleasevia Quantisnow
PLUS THERAPEUTICS Inc. logo

Plus Therapeutics to Host Investor Call to Discuss Leptomeningeal Cancer Related Acquisition and Topline Clinical Trial Data from the FORESEE Trial

ByQuantisnow·Wall Street's wire, on your screen.
PSTV· PLUS THERAPEUTICS Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PSTV (PLUS THERAPEUTICS Inc.) and more on Quantisnow.